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ABSTRACT
Background: Untreated malaria during pregnancy is detrimental to the health and survival of the mother, foetus and neonate 
due to its great potential to cause maternal anaemia, foetal death and intrauterine growth restriction leading to low birth 
weight. The foetal complications are due to impaired placental function that results from placental malaria parasitaemia as 
well as impaired foetal oxygenation from maternal anaemia. This study was conducted to determine the influence of 
placental malaria parasitaemia on infant birth weight.
Methodology: This was a prospective cross-sectional analytical study of 205 parturients recruited consecutively as they 
presented for delivery at the Federal Medical Centre, Yenagoa. An interviewer-administered questionnaire was used to 
collect data. After delivery, the neonates were weighed and placental blood was collected for microscopy to detect malaria 
parasites. Data was analysed using SPSS version 22.
Results: The prevalence of placental malaria parasitaemia was 13.7% and Plasmodium falciparum was the only parasite species 
detected. Placental malaria parasitaemia was associated with a reduction of the mean infant birth weight by 335 grams (P = 
0.01).
Conclusion: Malaria during pregnancy is still an important public health problem among our obstetric population, with a high 
prevalence of placental malaria parasitaemia and a significant negative effect on the birth weight of neonates. To enable the 
developing foetus achieve its full genetic growth potential, pregnant women should be encouraged to register early for 
antenatal care and utilize all the recommended malaria preventive measures.
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INTRODUCTION
hile malaria during pregnancy is Wa global public health problem, the burden is highest in sub-
Saharan Africa where it is estimated that, 
every year, 25-30 million pregnant women 
are at risk of acquiring the infection, and one 
in every four pregnant women have 
evidence of placental infection at the time of 
1,2delivery.  It is also estimated to account for 
26 per cent of severe anaemia in pregnancy 
and 35 per cent of preventable low birth 
1weight neonates in sub-Saharan Africa. 
These adverse outcomes have been 
described as consequences of sequestration 
of parasitized erythrocytes in the placenta. 
Because of this placental sequestration, 
peripheral blood film microscopy usually 
underestimates the prevalence of malaria in 
pregnancy; as the parasites are pooled from 
the peripheral blood to the placenta, 
peripheral blood film microscopy may not 
reveal parasitaemia despite a high burden of 
3,4 malaria parasites in the placenta. This may 
results in misdiagnosis and delay in 
instituting treatment with potentiation of the 
adverse effects of malaria in pregnancy.
Placental malaria parasitaemia occurs 
because the parasitized erythrocytes have 
the ability to adhere to chondroitin sulphate 
A on the syncytiotrophoblast of the 
5,6 placenta.  Malaria-induced low birth 
weight is a leading cause of infant morbidity 
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and mortality and it is estimated to account 
for between 62,000 and 363,000 infant deaths 
annually in Africa, translating to 3 to 17 infant 
1deaths per 1000 livebirths.  It increases the 
risk of death within the first month of life by 
7up to nine times.
Recent data from the United Nations 
8Children Fund  estimates that 13% of all 
babies born in sub-Saharan Africa are low-
birth weight; and malaria during pregnancy 
is thought to be an important contributor, 
accounting for up to 900,000 LBW neonates 
9,10every year.  Statistical analysis by Guyatt 
and Snow, of a collection of studies from sub-
Saharan Africa revealed that one-fifth of the 
LBW babies born to mothers in malaria 
endemic areas are due to placental malaria 
7infection while the mother was pregnant.  
Various studies have also shown that babies 
born to mothers with placental malaria 
infection are two to four times likely to be low 
birth weight than those born to mothers 
11without placental malaria infection.
Low birth weight is an important risk factor 
12 for neonatal and infant mortality. Studies 
from sub-Saharan Africa showed that 
neonatal and infant mortality are nine times 
and three times respectively, higher for LBW 
babies than for babies with normal birth 
7 weights. Guyatt and Snow, in their review of 
literature on the risks for the low birth weight 
7baby,  noted that the risk of both neonatal 
and infant mortality increase steadily as the 
birth weight decreases to below the LBW 
threshold (i.e. < 2500g). LBW is a well-
d o c u m e n t e d  r i s k  f a c t o r  f o r  p o o r 
neurosensory, cognitive and behavioural 
development as well as for limited school 
performance and academic achievement. It 
also places the individual at risk of chronic 
medical conditions like hypertension and 
13,14diabetes mellitus in adult life.
Malaria parasitized placentae have been 
observed to carry antibodies, cytokines and 
macrophages, which are indicative of an 
15,16active immune response.  This immune 
response may be responsible for the 
stimulation of early labour resulting in 
premature delivery and invariably preterm, 
17low birth weight neonates.  
The restriction of foetal growth in utero due 
to placental malaria parasitization (resulting 
in low birth weight) appears to relate to the 
interference with nutrient transport across 
the placenta to the foetus in a number of 
w a y s ;  a  h i g h  d e n s i t y  o f  p a r a s i t e s , 
longstanding placental infection and the 
associated immune response may result in 
the consumption of glucose and oxygen that 
would have gone to the foetus. Also, the 
thickening of the cytotrophoblast basement 
membrane, commonly found in histological 
studies of infected placentae may directly 
15interfere with nutrient transport to the fetus.  
Malaria-associated maternal anaemia has 
also been implicated as an independent 
contributor to foetal intrauterine growth 
restriction, most likely through the reduction 
7,18in oxygen transport to the fetus. 
Meta-analyses of intervention trials has 
demonstrated 43% reduction in low birth 
weight and 27% reduction in perinatal 
mortality with successful implementation of 
19 malaria prevention strategies in pregnancy.
These strategies include use of insecticide 
treated nets, intermittent preventive 
treatment of malaria in pregnancy with 
sulphadoxine-pyrimethamine and prompt 
appropriate case management of malaria in 
20pregnancy.  The adoption, application and 
widespread coverage of these preventive 
measures are especially deficient in the 
highly endemic areas of sub-Saharan Africa.
While it is well-recognized that placental 
malaria parasitization can result in the 
delivery of low birth weight neonates, 
different studies have presented contrasting 
results: some showing statistically significant 
relationship between placental malaria 
21,22parasitaemia and low infant birth weight,  
others demonstrat ing no significant 
23,24relationship.
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The above may imply that the effect of 
placental malaria on infant birth weight 
rather than being consistent, is variable, and 
may depend on, among other factors, the 
population studied.
Due to the important association of placental 
malaria and low infant birth weight, records 
of low birth weight deliveries has been 
incorporated as a key tool for monitoring and 
evaluating the effectiveness of malaria 
control programmes among pregnant 
women in Africa, since birth weight and 
parity are routinely recorded in many 
1, 25delivery centres across Africa.  This serves 
as a useful indicator at the health facility 
level ,  a l lowing Health workers and 
programme managers to observe the effects 
o f  m a t e r n a l  a n d  n e o n a t a l  h e a l t h 
interventions and to take corrective actions 
25 where necessary.  This study was conducted 
to determine the influence of placental 
malaria parasitaemia on infant birth weight.
METHODOLOGY
Study location: The study was conducted at 
the Federal Medical Centre, Yenagoa, the 
capital city of Bayelsa State in the South-
South region of Nigeria. 
Study design: This was a prospective cross-
sectional analytical study.
Study Population: This consisted of both 
booked and unbooked parturients
Inclusion Criteria: All pregnant women 
presenting to the delivery suite (for delivery), 
who gave consent to participate in the study.
Exclusion Criteria
1) Pregnant women with chronic medical 
disorders including diabetes mellitus, 
hypertension, chronic renal disease, 
sickle cell anaemia (haemoglobin 
g e n o t y p e  S S )  a s  w e l l  a s  t h o s e 
s e r o p o s i t i v e  f o r  H u m a n 
immunodeficiency virus.
2) P a r t u r i e n t s  w i t h  a n t e p a r t u m 
haemorrhage (abruptio placentae or 
placenta previa) and hypertensive 
disorders in pregnancy.
3) Pregnant women who take alcohol 
and/or tobacco products.
4) P r e g n a n t  w o m e n  w i t h  m u l t i p l e 
gestation.
5) Parturients with intrauterine foetal death 
or congenital foetal malformations.
6) Parturients who did not give consent.
Sample size calculation: The sample size for 
this study was calculated using the formula 
for cross-sectional studies  below;
2 2N = [Z  P(1-P)] / d
Where, N = Sample size; Z = Proportion of 
normal distribution corresponding to the 
required (5%) significance level (which is 
1.96);  P = Prevalence of placental malaria 
parasitaemia (which is 14% or 0.14 from a 
2 7previous study ) and d = Degree of 
accuracy/ precision expected (0.05)
Thus, N= 1.962 x 0.14 (1-0.14)/ 0.052 = 185.5
The sample size was thus calculated to be 
186. Giving allowance for a 10% attrition rate, 
the minimum sample size for the study was 
205 participants. The data for this study was 
collected over a period of five months 
(August 1, 2016 to December 31, 2016).
Sampling methodology: Every consecutive 
parturient who satisfied the eligibility 
criteria and gave consent was recruited until 
the sample size was obtained.
Study Protocol: With the study protocol in 
mind, standard laboratory methods as 
28 described by Cheesbrough  was used.
Data collection: After obtaining a signed 
informed consent  f rom the  e l ig ib le 
participant, a semi-structured interviewer-
administered questionnaire was filled. The 
questionnaire contained information that 
includes maternal age, marital status, 
educational status, occupation, gravidity, 
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antenatal care, malaria preventive measures, 
infant birth weight and placental blood 
microscopy for malaria parasite detection as 
well as parasite density.
Weighing of neonates: Immediately after 
d e l i v e r y  a n d  n e c e s s a r y  n e o n a t a l 
resuscitation, neonates were cleaned and 
weighed with an electronic baby weighing 
scale to the nearest 0.1gram. All low birth 
weight neonates had their gestational ages 
assessed within twenty four hours using the 
29Dubowitz Method  (see appendix III) by a 
neonatologist that covered the postnatal 
ward.
Placental blood collection: The aspiration 
30method of placental blood collection  was 
employed. This was done immediately after 
delivery of the placenta. The placenta (with 
its maternal surface facing up) was placed on 
a smooth surface. The maternal placental 
surface was washed with 200 millilitres of 
normal saline, and pierced (to a depth of 
about 0.5cm) with a sterile disposable syringe 
on a 14-gauge hypodermic needle. Two 
millilitres of placental blood was aspirated 
and put into an EDTA bottle. The specimen 
was labelled to correspond with the code on 
the questionnaire (for easy identification) 
and sent to the laboratory for processing 
(smearing, staining and microscopic 
examination). 
Laboratory procedure: Preparation and 
staining of the thick blood smear: Two drops 
of placental blood sample were placed on a 
slide using a small rubber pipette. Using the 
edge of a second slide, the drops of blood 
were joined and spread to make an even, 
thick smear and allowed to air-dry. The slide 
was immersed in the staining trough, 
containing 10% of freshly prepared Giemsa 
solution at pH 7.2 and contact maintained for 
10 minutes. The slide was then removed and 
allowed to dry.
Preparation and staining of the thin blood 
smear: One drop of placental blood was 
placed on a clean slide using a rubber pipette. 
The edge of a second slide held steadily at an 
angle of 45º to the first was used to spread the 
drop of blood to create the thin blood film. 
The thin film was fixed using Methanol 
(methyl alcohol) by maintaining contact with 
methanol for 10 seconds. The slide was then 
immersed in the staining trough containing 
10% of freshly prepared Giemsa solution at 
pH 7.2 and contact was maintained for 10 
minutes. The slide was then removed and 
allowed to dry.
Microscopic examination of slides for 
malaria parasite and determination of 
parasite density
The stained placental blood smears were 
examined under × 100 oil immersion lens of a 
light microscope. Malaria diagnosis was 
based on identification of asexual stages of 
Plasmodium species on the thick blood 
smear while the thin blood smear was used 
for species identification. 
Parasite density was determined by counting 
the number of parasites per high power field 
in the thick blood smear and reported as 
follows: + (1–10 parasites per 100 high power 
fields), ++ (11 – 100 parasites per 100 high 
power fields), +++ (1–10 parasites per high 
power field), and ++++ (>10 parasites per 
high power field). The slide was reported as 
negative if no parasite was identified per 100 
high power fields.
Data Analysis
Data regarding maternal age, marital status, 
e d u c a t i o n a l  s t a t u s ,  o c c u p a t i o n , 
parity/gravidity, antenatal care, malaria 
preventive measures, infant birth weight and 
placental blood microscopy for malaria 
parasite detection as well as parasite density 
was entered and statistical analysis  done 
using stat is t ical  software (SPSS for 
windows® version 22.0, SPSS Inc.; Chicago, 
USA). 
Univariate analysis for categorical variables 
was performed using chi-square test. 
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Maternal socio-demographic characteristics 
(Table 1) 
T w o  h u n d r e d  a n d  fi v e  p a r t u r i e n t s 
participated in the study. Their ages ranged 
from 14 to 45 years with a mean age of 29.9 
years. The modal age group was 30-34 years 
followed by the 25-29 years age group. The 
majority of the parturients had tertiary level 
of education (53.6%), were married (93.7%) 
a n d  e m p l o y e d  ( 7 1 . 7 % ) .  C h r i s t i a n s 
constituted 95.6% and the remaining 4.4% 
were Muslims. More than half (57.1%) were 
of the Ijaw ethnic group; the rest were Ibo 
(31.7%), Yoruba (4.9%), Hausa (1%) and other 
Nigerian tribes (5.3%). The maternal heights 
ranged from 1.45m-1.66m with an average 
height of 1.58±0.05m.
Prevalence and pattern of placental malaria 
parasitaemia
Two hundred and five placental blood films 
were analysed. Malaria parasite was detected 
in 28(13.7%) placental blood films and all had 
mild (+)  parasi taemia.  Plasmodium 
falciparum was the only malaria species 
detected in all the placental blood films.
Gestational age at delivery, Infant birth 
weight, APGAR scores and placental 
weight
The average gestational age at delivery was 
38.5±1.9weeks (Range = 31-42weeks); of 
these, 190(92.7%) parturients delivered at 
term, 13(6.3%) delivered before term and 
2(1.0%) delivered post-term.
The mean infant birth weight was 3213.5 +/- 
507.4grams (Range = 1490-4700grams). 
186(90.7%) were normal birth weight, 9(4.4%) 
were macrosomic and 10(4.9%) were low 
birth weight. Of the low birth weight babies, 
2(20%) were term while 8(80%) were preterm 
low birth weight babies. 
The APGAR score at the first minute was 
normal (≥7) in 88.3% and low (<7) in 11.7% of 
neonates. At the fifth minute, only 2% of 
n e o n a t e s  h a d  l o w  A P G A R  s c o r e s 
necessitating admission into the special care 
baby unit. The average placental weight was 
5 8 5 . 6 + / - 1 2 0 . 8 g r a m s  ( R a n g e  =  2 7 0 -
1095grams).
C o r r e l a t i o n  o f  p l a c e n t a l  m a l a r i a 
parasitaemia with infant birth weight
Mothers with placental malaria had babies 
with birth weights ranging from 1490g to 
3500g with an average of 2924±504g while 
those without placental malaria had babies 
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with birth weights ranging from 1640g to 
4700g with a mean of 3259±494g. There was 
thus a reduction in mean birth weight by 
335grams of babies born to mothers with 
placental malaria. This difference in mean 
birth weight was statistically significant 
(p=0.01).
Influence of placental malaria parasitaemia 
on APGAR scores, placental weight and 
gestational age at delivery.
The presence of malaria parasites in the 
placental blood had no significant association 
with the APGAR score at the 1st minute 
(p=0.33) and at the 5th minute (p=0.09). There 
was also no significant difference (p= 0.58) in 
the mean placenta weight of those in whom 
malaria were found (0.57kg) as compared to 
those without malaria (0.59kg). All the 
mothers with placental malaria parasitaemia 
delivered at term.
DISCUSSION
The socio-demographic profile of the 
participants showed patronage from the 
more educated and affluent women. It is 
likely that because of the higher hospital 
charges in tertiary hospitals, a good number 
of the less educated and poorer women 
patronize the primary and secondary health 
care centres with lower hospital charges. The 
predominant tribe and religion in the area of 
s t u d y  w e r e  I j a w  a n d  C h r i s t i a n i t y 
respectively; this was reflected in the 
preponderance of Ijaw and Christian women 
in the study. The older maternal age 
predominance may have also accounted for 
the preponderance of parturients that were 
multiparous.
The prevalence of placental malaria 
parasitaemia of 13.7% found in this study is 
similar to the prevalence of 14% reported by 
Mokuolu et al  in a study from four 
27geopolitical zones in Nigeria  and that 
(13.0%) reported by Falade et al in south 
31 western Nigeria but much lower than the 
2365.2% prevalence reported by Nyengidiki et al  
in Port Harcourt within the same geographical 
zone with Bayelsa where this study was 
conducted. The lower prevalence in this study may 
be due to the high level of education among the 
parturients which may have contributed to 
their health awareness with a positive impact 
on their health and the effective malaria 
preventive measures utilized by the 
parturients including IPTpSP (88.3%) and 
ITN (50.2%); other factors may include a high 
level of community acquired immunity and 
 23the quality of antenatal care.
The finding that Plasmodium falciparum was 
the only parasite species detected in all the 
placental blood films in this study confirms 
previous reports that placental malaria is an 
exclusive feature of plasmodium falciparum 
3 2i n f e c t i o n  i n  p r e g n a n c y  a n d  t h a t 
Plasmodium falciparum is  the most 
prevalent species in Nigeria accounting for 
33about 98% of malaria cases in the country.
While placental malaria parasitaemia was 
not significantly associated with low infant 
birth weight in this study, it was associated 
with a statistically significant reduction in the 
mean birth weight. This finding may be due 
to subtle placental dysfunction from mild 
placental parasitaemia. A similar finding of a 
statistically significant reduction in the mean infant 
birth weight among parturients with placental 
malaria parasitaemia was reported by Falade in 
31Ibadan.  The severity of the placental 
parasitization may thus correlate directly with 
the degree of reduction in infant birth weight.
Malaria in pregnancy is still a public health 
problem. The level of utilization of the 
preventive measures is still far from what is 
desired. The observed impact of this 
condition on the pregnant woman and her 
baby adds justification for advocacy from all 
stakeholders to promote the utilization of 
malaria preventive measures during 
pregnancy in order to achieve a reduction in 
the burden of the disease.
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CONCLUSION
Malaria during pregnancy is still an 
important public health problem among our 
obstetric population, with a high prevalence 
of placental malaria parasitaemia and a 
significant negative effect on the birth weight 
of neonates. To enable the developing foetus 
achieve its full genetic growth potential, 
pregnant women should be encouraged to 
register early for antenatal care and utilize all 
the recommended malaria preventive 
measures.
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